Jean Michon

Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry.

D. Frappaz, T. Klingebiel, F. Chauvin, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations.

Erin K. Hedlund, Michael C. Rusch, E. Mardis, 2014, Cancer discovery.

Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification

O. Delattre, J. Klijanienko, H. Brisse, 2007, British Journal of Cancer.

Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification

F. Speleman, J. Vandesompele, O. Delattre, 2001, International journal of cancer.

Presence of tumor cells in bone marrow but not in blood is associated with adverse prognosis in patients with Ewing's tumor. Société Française d'Oncologie Pédiatrique.

O. Delattre, M. Peter, J. Zucker, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sensitive detection of occult Ewing's cells by the reverse transcriptase-polymerase chain reaction.

G. Thomas, O. Delattre, T. Melot, 1995, British Journal of Cancer.

Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations.

Li Ding, Xiaotu Ma, Jinghui Zhang, 2014, Cancer discovery.

hSNF5/INI1‐deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities

A. Nicolas, C. Sainte-Rose, R. Bouvier, 2007, The Journal of pathology.

Quality assessment of genetic markers used for therapy stratification.

F. Speleman, O. Delattre, G. Tonini, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Criteria for evaluation of disease extent by 123I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force

Lewington, K. Matthay, S. Cohn, 2010, British Journal of Cancer.

Incidence and prognostic value of tumour cells detected by RT–PCR in peripheral blood stem cell collections from patients with Ewing tumour

M. Peter, J. Vermeulen, G. Pierron, 2006, British Journal of Cancer.